XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024   10,814,960        
Beginning balance at Dec. 31, 2024 $ 132,871,760 $ 108,150 $ 97,709,231 $ 91,582,986 $ (10,722,410) $ (45,806,197)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,968,310     1,968,310    
Other comprehensive income (loss) 1,276,182         1,276,182
ESOP shares earned 178,483   (5,347)   183,830  
Stock based compensation 363,459   363,459      
Common stock dividends ($0.15 per share) (1,492,715)     (1,492,715)    
Repurchase of common stock (in shares)   (324,696)        
Repurchase of common stock (4,233,622) $ (3,247) (4,230,375)      
Ending balance (in shares) at Mar. 31, 2025   10,490,264        
Ending balance at Mar. 31, 2025 $ 130,931,857 $ 104,903 93,836,968 92,058,581 (10,538,580) (44,530,015)
Beginning balance (in shares) at Dec. 31, 2025 10,501,260 10,501,260        
Beginning balance at Dec. 31, 2025 $ 145,781,100 $ 105,013 92,897,260 97,324,605 (9,987,093) (34,558,685)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,785,291     2,785,291    
Other comprehensive income (loss) (2,466,272)         (2,466,272)
ESOP shares earned 187,751   3,922   183,829  
Stock based compensation 87,493   87,493      
Common stock dividends ($0.15 per share) $ (1,464,950)     (1,464,950)    
Ending balance (in shares) at Mar. 31, 2026 10,501,260 10,501,260        
Ending balance at Mar. 31, 2026 $ 144,910,413 $ 105,013 $ 92,988,675 $ 98,644,946 $ (9,803,264) $ (37,024,957)